| Nanci Jo Billock, MD | |
|
6903 Burlington Pike, Suite A, Florence, KY 41042-1618 | |
| (859) 282-6700 | |
| (859) 282-6760 |
| Full Name | Nanci Jo Billock |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 6903 Burlington Pike, Florence, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386936821 | NPI | - | NPPES |
| 7100181690 | Medicaid | KY |
| Entity Name | Trihealth G Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295862944 PECOS PAC ID: 0749222651 Enrollment ID: O20050601000358 |
News Archive
Hypoxic tumor cells usually resist radiation and chemotherapy, making them a key challenge in treating cancer. Researcher Xin Chen, Ph.D. believes that MR-guided focused ultrasound could reduce this problem, benefiting patients with malignant solid tumors in areas such as the liver, prostate and breast.
Walking for just 30 minutes three times per week could improve the quality of life for those with advanced cancer, a new study published in the BMJ Open journal has found.
Chattem, Inc., a leading marketer and manufacturer of branded consumer products, today announced results for the year and fiscal fourth quarter ended November 30, 2009.
Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex's biosimilar candidate to Genentech's LUCENTIS (ranibizumab injection).
› Verified 5 days ago
| Entity Name | Trihealth H Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811215742 PECOS PAC ID: 1850570458 Enrollment ID: O20110128000356 |
News Archive
Hypoxic tumor cells usually resist radiation and chemotherapy, making them a key challenge in treating cancer. Researcher Xin Chen, Ph.D. believes that MR-guided focused ultrasound could reduce this problem, benefiting patients with malignant solid tumors in areas such as the liver, prostate and breast.
Walking for just 30 minutes three times per week could improve the quality of life for those with advanced cancer, a new study published in the BMJ Open journal has found.
Chattem, Inc., a leading marketer and manufacturer of branded consumer products, today announced results for the year and fiscal fourth quarter ended November 30, 2009.
Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex's biosimilar candidate to Genentech's LUCENTIS (ranibizumab injection).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nanci Jo Billock, MD 375 Dixmyth Ave, Cincinnati, OH 45220-2475 Ph: (513) 862-1400 | Nanci Jo Billock, MD 6903 Burlington Pike, Suite A, Florence, KY 41042-1618 Ph: (859) 282-6700 |
News Archive
Hypoxic tumor cells usually resist radiation and chemotherapy, making them a key challenge in treating cancer. Researcher Xin Chen, Ph.D. believes that MR-guided focused ultrasound could reduce this problem, benefiting patients with malignant solid tumors in areas such as the liver, prostate and breast.
Walking for just 30 minutes three times per week could improve the quality of life for those with advanced cancer, a new study published in the BMJ Open journal has found.
Chattem, Inc., a leading marketer and manufacturer of branded consumer products, today announced results for the year and fiscal fourth quarter ended November 30, 2009.
Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex's biosimilar candidate to Genentech's LUCENTIS (ranibizumab injection).
› Verified 5 days ago
Ms. Stephanie Marie Deangelis, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7370 Turfway Rd, Florence, KY 41042 Phone: 859-212-5125 Fax: 859-212-5099 | |
Dr. April Michelle Tillery, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7370 Turfway Rd, Suite 250, Florence, KY 41042 Phone: 859-341-5550 Fax: 859-344-3782 | |
Kiran Bhatia, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7370 Turfway Rd, Ste 390, Florence, KY 41042 Phone: 859-212-5125 Fax: 859-212-5099 | |
Dr. Maria D Reid, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6903 Burlington Pike, Suite A, Florence, KY 41042 Phone: 859-282-6700 Fax: 859-282-6760 | |
Dr. Jonathan Koop, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7370 Turfway Rd, Ste 390, Florence, KY 41042 Phone: 859-212-5125 Fax: 859-212-5099 | |
Gary Kanter, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6903 Burlington Pike, Florence, KY 41042 Phone: 859-282-6700 Fax: 859-282-6760 | |
Jacqueline T Hanson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6907 Burlington Pike, Florence, KY 41042 Phone: 859-525-1846 Fax: 859-647-3355 |